semlerresearch

Part of US based
Semler Group of Companies,
in business since 1946

Sitemap

YOU ARE HERE: Home News & Events Highlights
Highlights
SRC inspected and approved by ANVISA

The inspection focused on the bio-equivalence study conducted for the product. ANVISA inspectors visited the facility to review study documents generated at the Clinical facility, Salem and the Bioanalytical facility, Bangalore. The study was approved by the regulatory.

 
Fresh Round of Investment and Growth Plans for SRC

Agoura Hills, California, United States, Tuesday, October 01, 2013 -- (Business Wire India)

Semler Research Centre Pvt. Ltd. (SRC), a leading Contract Research Organization based in Bengaluru, India entered into an agreement with Excel Dwellings (EDI) for development of products. EDI will fund intially USD 5 Million which will be utilised for product development opportunities. EDI will work closely with SRC for development of products in regulated markets through an exclusive manufacturing and distribution partner.

Readmore…

 
SRC inspected and approved by EMA

The inspection focused on the bio-equivalence study conducted for the product. EMA inspectors visited the facility to review study documents generated at Clinical facility and Bioanalytical facility, Bangalore. The study was approved by the regulatory.

 
SRC successfully completes 7th USFDA Inspection

The inspection focused on the bio-equivalence study conducted for the product. USFDA inspectors visited the facility to review study documents generated at Clinical facility and Bioanalytical facility, Bangalore. The study was approved by the regulatory.

 
SRC inspected and approved by ISP MOH, Chile

Inspection was focused on the acceptance of the infrastructure available for the conduct of BA/BE study along with Standard operating procedures. Inspection involved Clinical facility and Bioanalytical facility, Bangalore.

The facility was accepted and certified for the conduct of BA/BE study.

 


Quick Contact

INDIA Tel: +91 80 4262 7200

US Tel: +1 818 760 1000

info@semlerresearch.com